文献速递血栓与止血

根据铟-111血小板闪烁显像识别的血小板破坏部位观察免疫性血小板减少症的病程

Course of immune thrombocytopenia according to the site of platelet destruction identified by indium-111 platelet scintigraphy.
PubMed 文献 · Br J Haematol · 2024-10-15

该回顾性单中心研究纳入2009至2018年接受至少一次铟-111血小板闪烁显像的成人原发免疫性血小板减少症患者,比较单纯肝脏破坏组(33例)与单纯脾脏破坏组(97例)。肝脏组诊断年龄、心血管疾病比例、器官特异性自身免疫病比例、激素依赖比例及利妥昔单抗失败率均更高,复发更频繁;脾脏组脾切除后79%在中位3.4年随访结束时无复发生存。

要点

  • 单纯肝脏破坏组诊断年龄、心血管事件及器官特异性自身免疫病比例高于非脾切除的脾脏破坏组。
  • 肝脏破坏组激素依赖比例及利妥昔单抗失败率更高,复发更频繁。
  • 脾切除仅在脾脏破坏组进行,79%在中位3.4年随访结束时无复发生存。

核心结论

  • 单纯肝脏扣押的患者年龄更大、心血管事件及器官特异性自身免疫病更多、激素依赖更强、复发更多且利妥昔单抗应答率降低,提示对免疫调节治疗更 refractoriness。
  • 单纯脾脏扣押的患者对脾切除应答良好。

研究设计与样本

  • 回顾性单中心研究,纳入2009至2018年接受至少一次铟-111血小板闪烁显像的成人原发免疫性血小板减少症患者。
  • 33例为单纯肝脏血小板破坏(H组),97例为单纯脾脏破坏(S组)。

主要发现

  • H组诊断年龄中位数(p < 0.001)、相关心血管疾病比例(p < 0.001)、器官特异性自身免疫病比例(p = 0.02)、激素依赖比例(p = 0.003)及利妥昔单抗失败率(p = 0.01)均高于S组中非脾切除患者,复发更频繁(p = 0.03)。
  • 脾切除仅在S组患者中进行,79%在中位3.4年随访结束时无复发生存,16%复发。
  • 多因素分析中,仅器官特异性自身免疫或炎症性疾病病史与肝脏扣押显著相关(OR = 4.3,95% CI = 1.2-15,p = 0.02)。

临床怎么用

  • 本研究中心的做法是不对肝脏扣押患者进行脾切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In primary immune thrombocytopenia (ITP), predictors of disease evolution and treatment response are needed. Data based on the site of platelet destruction are scarce. We performed a retrospective single-centre study of adult patients with primary ITP undergoing at least one Indium-111 platelet scintigraphy (IPS) between 2009 and 2018. Thirty-three patients had isolated hepatic platelet destruction (H-group), and 97 isolated splenic destruction (S-group). Median age at diagnosis (p < 0.001), proportion of associated cardiovascular (p < 0.001), organ-specific autoimmune diseases (p = 0.02), dependence on steroids (p = 0.003) and failure to rituximab (p = 0.01) were higher and relapse more frequent (p = 0.03) in H-group compared to non-splenectomized patients in S-group. Splenectomy was only performed in patients from S-group (as patients with hepatic sequestration are not splenectomized in our centre): 79% were in relapse-free remission at the end of a median 3.4-year post-IPS follow-up, 16% relapsed. In multivariate analyses, only a history of organ-specific autoimmune or inflammatory disease was significantly associated with hepatic sequestration (OR = 4.3, 95% CI = 1.2-15, p = 0.02). Patients with isolated hepatic sequestration were older, had more cardiovascular events and organ-specific autoimmune diseases, greater dependence on steroids, more relapses and a decreased response rate to rituximab suggesting an increased refractoriness to immunomodulatory therapies. Patients with isolated splenic sequestration responded well to splenectomy.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Durand P, Pottier V, Debordeaux F, et al. Course of immune thrombocytopenia according to the site of platelet destruction identified by indium-111 platelet scintigraphy. Br J Haematol. 2024. PMID: 39407432. doi:10.1111/bjh.19833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。